I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

Oh My Meds LogoOh My Meds expands nationwide with personalized peptide therapies, offering virtual care and fast home ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...